Publications

Manuscripts

2025

  1. Toljan K, Amin M, Ontaneda D. Central vein sign and paramagnetic rim lesion abbreviated counting methods for diagnosis of multiple sclerosis: a systematic review and meta-analysis. Clinical Radiology. 2025 Jun 11:106984.
  2. Amin M, Nakamura K, Daboul L, O’Donnell C, Cao Q, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi PA. Incorporation of the central vein sign into the McDonald criteria. Multiple Sclerosis and Related Disorders. 2025 Jan 1;93:106182.
  3. Toljan K, Aboseif A, Amin M. Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 2025 Apr 1;96:106352.
  4. Amin M, Harvey T, Pineda DM, Tai MH, Shao Q, Brown B, Gadkari A, Moss B, Conway DS, Hersh CM. Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice. Neurodegenerative Disease Management. 2025 Jan 23:1-0.

2024

  1. Aboseif A, Amin M, Macaron G, Ontaneda D. Discordance of reported multiple sclerosis clinical course amongst patients and providers. Journal of Neuroimmunology. 2024 Oct 15;395:578443.
  2. Amin M, Martínez-Heras E, Ontaneda D, Prados Carrasco F. Artificial Intelligence and Multiple Sclerosis. Current Neurology and Neuroscience Reports. 2024 Jun 28:1-1.
  3. Carlson AK, Amin M, Cohen JA. Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs. 2024 Mar 14:1-20.

2023

  1. Amin M, Nakamura K, Ontaneda D. Differentiating multiple sclerosis from non-specific white matter changes using a convolutional neural network image classification model. Multiple Sclerosis and Related Disorders. 2023 Dec 31:105420.
  2. Daboul L, O’Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi PA, Cree BA, Freeman L. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis Journal. 2023 Dec 13:13524585231214360.
  3. Aboseif A, Li Y, Amin M, Lapin B, Milinovich A, Abbatemarco JR, Cohen JA, Punia V, Rae-Grant AD, Galioto R, Kunchok A. Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis. Neurology-Neuroimmunology Neuroinflammation. 2024 Jan 1;11(1).
  4. Amin M, Aboseif A, Southard K, Uchino K, Kiczek M, Hajj-Ali R, Kharal GA. The prevalence of radiological cerebral amyloid angiopathy-related inflammation in patients with cerebral amyloid angiopathy. Journal of Stroke and Cerebrovascular Diseases. 2023 Dec 1;32(12):107436.
  5. Aboseif A, Amin M, Bena J, Nakamura K, Macaron G, Ontaneda D. Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple Sclerosis. International Journal of MS Care. 2023 Oct 20.
  6. Wilcox O, Amin M, Hancock L, Nakamura K, Lace J, Ontaneda D, Galioto R. Associations Between Cognitive Impairment and Neuroimaging in Patients with Multiple Sclerosis. Archives of Clinical Neuropsychology. 2023 Sep 12:acad070.
  7. Amin M, Uchino K, Hajj-Ali RA. Central Nervous System Vasculitis: Primary Angiitis of the Central Nervous System and Central Nervous System Manifestations of Systemic Vasculitis. Rheumatic Disease Clinics. 2023 May 2.
  8. Vishwanath R, Amin M, Cierny M, Tan C, Buletko AB. Pearls & Oy-sters: Mitral Annular Calcification as a Cause of Ischemic Stroke: A Case Report. Neurology. 2023 Mar 29.
  9. Toljan K, Mahadeen A, Amin M, Rensel M, Jones SE, Ontaneda D, Kunchok AC. Pearls & Oy-sters: Hemorrhagic Myelitis Following SARS-CoV-2 Infection. Neurology. 2023 Mar 29.s

2022

  1. Toljan K, Amin M, Kunchok A, Ontaneda D. New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure. Journal of Neuroimmunology. 2022 Jan 15;362:577785.
  2. Huang M, Shoskes A, Migdady I, Amin M, Hasan L, Price C, Uchino K, Choi CW, Hernandez AV, Cho SM. Does targeted temperature management improve neurological outcome in extracorporeal cardiopulmonary resuscitation (ECPR)?. Journal of Intensive Care Medicine. 2022 Feb;37(2):157-67.
  3. Migdady I, Shoskes A, Amin M, Cho SM, Rae-Grant A, George P. Determination of Brain Death in Patients Undergoing Short-Term Mechanical Circulatory Support Devices. Heart, Lung and Circulation. 2022 Feb 1;31(2):239-45.
  4. Daboul L, O’Donnell CM, Cao Q, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi P, Cree BA. Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis. American Journal of Roentgenology. 2022 Aug 17:1-1.
  5. Amin M, Newey C, Punia V, Hantus S, Nazha A. Personalized model to predict seizures based on dynamic and static continuous EEG monitoring data. Epilepsy & Behavior. 2022 Oct 1;135:108906.
  6. Amin M, Hersh CM. Updates and advances in multiple sclerosis neurotherapeutics. Neurodegenerative Disease Management. 2022 Oct(0).

2021

  1. Amin M, Ontaneda D. Thalamic injury and cognition in multiple sclerosis. Frontiers in Neurology. 2021 Feb 5;11:623914.
  2. Migdady I, Amin M, Shoskes A, Hassett C, Rae-Grant A, Snider SB, Greer DM, Cho SM, George P. Outcomes, time-trends, and factors associated with ancillary study use for the determination of brain death. Critical care medicine. 2021 Apr 8;49(9):e840-8.
  3. Amin M, Li Y, Daly TM, Marquardt RJ. Evaluating the frequency of positive paraneoplastic antibodies and associated malignancy risk. Journal of the Neurological Sciences. 2021 Apr 15;423:117347.
  4. Rose DR, Amin M, Ontaneda D. Prediction in treatment outcomes in multiple sclerosis: challenges and recent advances. Expert Review of Clinical Immunology. 2021 Nov 2;17(11):1187-98.
  5. Migdady I, Amin M, Shoskes A, Hassett C, Cho SM, George P, Rae-Grant A. The effect of incorporating an arterial pH target during apnea test for brain death determination. Journal of Intensive Care. 2021 Dec;9(1):1-8.
  6. Mahajan KR, Amin M, Poturalski M, Lee J, Herman D, Zheng Y, Androjna C, Howell M, Fox RJ, Trapp BD, Jones SE. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray–white matter junction correlates with iron-enriched macrophages. Multiple Sclerosis Journal. 2021 Dec;27(14):2159-69.
  7. Amin M, Mays M, Polston D, Flanagan EP, Prayson R, Kunchok A. Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity. Journal of neuroimmunology. 2021 Dec 15;361:577743.

2020

  1. Amin M, Purohit M, Calabrese C, Prayson R, Li Y. Hypertrophic pachymeningitis and choroid plexitis in IgG-4 related disease. Neurology: Clinical Practice. 2020 Oct 6.

2016

  1. Salajegheh A, Vosgha H, Rahman MA, Amin M, Smith RA, Lam AK. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Human pathology. 2016 May 1;51:75-85.
  2. Ariana A, Amin M, Pakneshan S, Dolan-Evans E, Lam AK. Integration of traditional and e‐learning methods to improve learning outcomes for dental students in histopathology. Journal of dental education. 2016 Sep;80(9):1140-8.
  3. Madge PD, Maggioni A, Pascolutti M, Amin M, Waespy M, Bellette B, Thomson RJ, Kelm S, von Itzstein M, Haselhorst T. Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt’s lymphoma (BL) Daudi cells by NMR spectroscopy. Scientific reports. 2016 Nov 3;6(1):1-2.

2015

  1. Salajegheh A, Vosgha H, Rahman AM, Amin M, Smith RA, Lam AK. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer. Endocrinology. 2015;55:183-96.
  2. Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Experimental and molecular pathology. 2015 Jun 1;98(3):411-8.

Book Chapters

2023

  1. Amin M, Moss B, Culver D. Neurosarcoidosis. In: Bilaçeroğlu S, ed. Sarcoidosis in every aspect from Pathogenesis to Treatment. 1st ed. Ankara: Türkiye Clinics; 2021. p.65-72.

2018

  1. Amin M, Islam F, Gopalan V, Lam AK. Detection and quantification of MicroRNAs in esophageal adenocarcinoma. InEsophageal Adenocarcinoma 2018 (pp. 257-268). Humana Press, New York, NY.

2016

  1. Salajegheh A, Amin M (2016) Transforming Growth Factor Beta-Receptor Type II (TGFβR2). In:  Angiogenesis in Health, Disease and Malignancy. Springer International Publishing, Cham, pp 339-343.
  2. Salajegheh A, Amin M (2016) Platelet-Activating Factor. In:  Angiogenesis in Health, Disease and Malignancy. Springer International Publishing, Cham, pp 253-260.
  3. Salajegheh A, Amin M (2016) Platelet-Derived Endothelial Cell Growth Factor (PDGF). In:  Angiogenesis in Health, Disease and Malignancy. Springer International Publishing, Cham, pp 229-234.